Precigen PGEN
NASDAQ PGEN
$7.11 -0.03 (-0.49%)
As of: Sep 4, 2026 · 3:59 PM EDT

Precigen (PGEN) Long-Term Debt Repayments (2013 - 2023)

Precigen (PGEN) posted quarterly Long-Term Debt Repayments of $13.9 million for Q2 2023, up 12193.81% year-over-year from N/an in Q2 2022, and down 52.63% quarter-over-quarter from $29.3 million in Q1 2023.

Analysis

Precigen (PGEN) Long-Term Debt Repayments (2013 - 2023) Analysis & Trends

Precigen (PGEN) has reported Long-Term Debt Repayments for 11 consecutive years, with $13.9 million the latest figure, recorded in Q2 2023.

  • In Q2 2023, Long-Term Debt Repayments rose 12193.81% year-over-year to $13.9 million; the TTM figure through Mar 2024 stood at $13.9 million (down 92.47% YoY), while the FY2023 annual figure was $43.2 million, down 72.17% from the prior year.
  • Long-Term Debt Repayments declined to $13.9 million in Q2 2023 per PGEN's latest filing, from $29.3 million in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $115.7 million in Q3 2022 and bottomed at $113000.0 in Q2 2022.
  • Historically, Long-Term Debt Repayments has averaged $11.1 million across 5 years, with a median of $137500.0 in 2019.
  • Annual changes were most pronounced in 2019 — Long-Term Debt Repayments slipped 29.9% — and 2022, when it jumped 98817.95%.
  • Precigen's Long-Term Debt Repayments stood at $154000.0 in 2019, then decreased by 22.08% to $120000.0 in 2020, then fell by 4.17% to $115000.0 in 2021, then jumped by 34058.26% to $39.3 million in 2022, then slumped by 64.64% to $13.9 million in 2023.
  • Business Quant data shows PGEN's Long-Term Debt Repayments at $13.9 million in Q2 2023, $29.3 million in Q1 2023, and $39.3 million in Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Repayments (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 17.05 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Precigen 2.53 Bn 2.53 Bn 52.17 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 13.89 Mn
Mar 31, 2023 29.33 Mn
Dec 31, 2022 39.28 Mn
Sep 30, 2022 115.73 Mn
Jun 30, 2022 113,000.00
Mar 31, 2022 164,000.00
Dec 31, 2021 115,000.00
Sep 30, 2021 117,000.00
Jun 30, 2021 118,000.00
Mar 31, 2021 116,000.00
Dec 31, 2020 120,000.00
Sep 30, 2020 117,000.00
Jun 30, 2020 121,000.00
Mar 31, 2020 132,000.00
Dec 31, 2019 154,000.00
Sep 30, 2019 143,000.00
Jun 30, 2019 143,000.00
Mar 31, 2019 178,000.00
Dec 31, 2018 138,000.00
Sep 30, 2018 204,000.00